SIRT1 and depressive symptom measurement: To determine the contribution of SIRT1 to the development of depression, we pharmacologically activated or inhibited SIRT1 function with resveratrol and selisistat (EX-527), respectively, during juvenile age and measured the effects on depression-related behavior in adulthood.